Overview A Study of ALM-488 to Highlight Nerves in Patients Undergoing Head & Neck Surgery Status: Active, not recruiting Trial end date: 2022-08-31 Target enrollment: Participant gender: Summary Phase 1/2 study of ALM-488 to highlight nerves in patients undergoing head & neck surgery. Phase: Phase 1/Phase 2 Details Lead Sponsor: Alume Biosciences, Inc.